MANGALAM GLOBAL ENTERPRISE
Back to Balance Sheet
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of MANGALAM GLOBAL ENTERPRISE ?
| Year | Current Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Current Liabilities of MANGALAM GLOBAL ENTERPRISE Trending?
| Years | Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Current Liabilities of peers of MANGALAM GLOBAL ENTERPRISE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANGALAM GLOBAL ENTERPRISE | ₹484.2 Cr | -2.5% | -1% | 19% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,289.5 Cr | 2.1% | -0.7% | -19.6% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,789.5 Cr | -4.6% | -8.7% | 5.5% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,979.8 Cr | -1.4% | 4.2% | -23.9% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,055.4 Cr | -0.3% | -11.4% | -37.7% | Stock Analytics | |
| INDO US BIOTECH | ₹247.0 Cr | -1.5% | 1.4% | -66.9% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANGALAM GLOBAL ENTERPRISE | -2.5% |
-1% |
19% |
| SENSEX | -0.4% |
-0.3% |
3.9% |
You may also like the below Video Courses